AAA
Affinity Asset Advisors’s Kura Oncology KURA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-687,785
| Closed | -$13.4M | – | 85 |
|
2024
Q3 | $13.4M | Buy |
687,785
+37,785
| +6% | +$738K | 1.83% | 17 |
|
2024
Q2 | $13.4M | Sell |
650,000
-80,492
| -11% | -$1.66M | 1.54% | 17 |
|
2024
Q1 | $15.6M | Buy |
730,492
+538,957
| +281% | +$11.5M | 1.93% | 12 |
|
2023
Q4 | $2.75M | Sell |
191,535
-665,000
| -78% | -$9.56M | 0.5% | 44 |
|
2023
Q3 | $7.81M | Sell |
856,535
-53,782
| -6% | -$490K | 2.2% | 12 |
|
2023
Q2 | $9.63M | Buy |
910,317
+553,030
| +155% | +$5.85M | 3.36% | 9 |
|
2023
Q1 | $4.37M | Buy |
357,287
+88,540
| +33% | +$1.08M | 1.44% | 19 |
|
2022
Q4 | $3.34M | Sell |
268,747
-407,006
| -60% | -$5.05M | 1.31% | 23 |
|
2022
Q3 | $9.23M | Sell |
675,753
-252,503
| -27% | -$3.45M | 2.58% | 7 |
|
2022
Q2 | $17M | Buy |
928,256
+4,109
| +0.4% | +$75.3K | 7.17% | 2 |
|
2022
Q1 | $14.9M | Buy |
924,147
+364,147
| +65% | +$5.86M | 2.38% | 3 |
|
2021
Q4 | $7.84M | Buy |
560,000
+30,000
| +6% | +$420K | 2.85% | 10 |
|
2021
Q3 | $9.93M | Buy |
530,000
+105,000
| +25% | +$1.97M | 2.51% | 5 |
|
2021
Q2 | $8.86M | Buy |
425,000
+60,000
| +16% | +$1.25M | 3.17% | 5 |
|
2021
Q1 | $10.3M | Buy |
365,000
+105,000
| +40% | +$2.97M | 3.5% | 5 |
|
2020
Q4 | $8.49M | Buy |
+260,000
| New | +$8.49M | 4.5% | 4 |
|